Abliva’s Chief Medical Officer, Magnus Hansson, speaks about drug development in the primary mitochondrial disease space, and Abliva’s lead candidate KL1333.
source
Abliva – Drug Development – Mito Disease
Mitochondria News for Athletes
Abliva’s Chief Medical Officer, Magnus Hansson, speaks about drug development in the primary mitochondrial disease space, and Abliva’s lead candidate KL1333.
source
